Wall Street brokerages expect that UnitedHealth Group (NYSE:UNH) will report earnings of $2.92 per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for UnitedHealth Group’s earnings. The lowest EPS estimate is $2.85 and the highest is $3.00. UnitedHealth Group posted earnings of $2.37 per share during the same quarter last year, which suggests a positive year over year growth rate of 23.2%. The company is expected to report its next earnings report before the market opens on Tuesday, April 17th.
On average, analysts expect that UnitedHealth Group will report full-year earnings of $12.52 per share for the current fiscal year, with EPS estimates ranging from $12.40 to $12.60. For the next financial year, analysts anticipate that the company will report earnings of $14.05 per share, with EPS estimates ranging from $13.38 to $14.47. Zacks’ EPS averages are an average based on a survey of research firms that that provide coverage for UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the business earned $2.11 earnings per share.
Shares of NYSE UNH traded up $6.79 during trading on Wednesday, reaching $231.07. The company had a trading volume of 1,924,586 shares, compared to its average volume of 3,891,886. UnitedHealth Group has a 52 week low of $164.96 and a 52 week high of $250.79. The company has a market cap of $217,027.44, a PE ratio of 22.66, a P/E/G ratio of 1.31 and a beta of 0.77. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 29.79%.
In related news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, March 19th. The shares were sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the completion of the transaction, the director now owns 1,771,257 shares in the company, valued at $397,399,220.52. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Steven H. Nelson sold 14,233 shares of the business’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $230.22, for a total transaction of $3,276,721.26. Following the transaction, the chief executive officer now owns 18,219 shares of the company’s stock, valued at approximately $4,194,378.18. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,015 shares of company stock valued at $17,879,199. Corporate insiders own 0.89% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 399.3% in the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after buying an additional 3,304,902 shares during the period. Jennison Associates LLC boosted its holdings in shares of UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after buying an additional 3,289,470 shares during the period. Egerton Capital UK LLP acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $368,905,000. Amundi Pioneer Asset Management Inc. boosted its holdings in shares of UnitedHealth Group by 72.1% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 1,919,846 shares of the healthcare conglomerate’s stock valued at $423,249,000 after buying an additional 804,091 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of UnitedHealth Group by 22.4% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,323,180 shares of the healthcare conglomerate’s stock valued at $953,088,000 after buying an additional 792,527 shares during the period. Hedge funds and other institutional investors own 86.78% of the company’s stock.
WARNING: “$2.92 Earnings Per Share Expected for UnitedHealth Group (UNH) This Quarter” was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.chaffeybreeze.com/2018/04/16/2-92-earnings-per-share-expected-for-unitedhealth-group-unh-this-quarter.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.